Zhao Yang | Precision Oncology | Excellence in Research

Published on by Environmental Scientists

Assist. Prof. Dr Zhao Yang | Precision Oncology | Excellence in Research

Associate Professor of Biomedical Engineering, Beijing University of Chemical technology, Beijing university of chemical technology, China📚

Zhao Yang is an Associate Professor in Biomedical Engineering at Beijing University of Chemical Technology, where he also directs the Research Center of Precision Medicine. His academic journey began at Jilin University, where he earned his Bachelor’s degree in Biochemistry and Molecular Biology. He later completed his Ph.D. at the Chinese Academy of Sciences. Zhao has significantly contributed to the field of precision oncology, focusing on cancer stem cells, biomarkers, and drug-targeted therapy.

Profile

Orcid

Education 🎓

Zhao Yang obtained his Bachelor of Science in Biochemistry and Molecular Biology from Jilin University (2006-2010). He went on to complete his Ph.D. in the same field at the Chinese Academy of Sciences, specializing in infection and immunity (2010-2015).

Experience 💼

With extensive experience in precision medicine, Zhao is involved in cutting-edge research on the molecular mechanisms of cancer progression. He has led several major research projects, including studies on bladder cancer progression and prostate cancer malignancy. Zhao has also contributed to over 85 publications in reputable journals.

Research Interest 🔬

Zhao Yang’s research focuses on precision oncology, particularly in understanding cancer stem cells, biomarkers, and drug-targeted therapies. His work includes studies on the molecular events in bladder cancer and prostate cancer, as well as research into novel cancer therapies using CRISPR-Cas systems and non-hepatic targeting nanozyme carriers.

Award 🏆

Zhao Yang is a prominent researcher in the field of biomedical engineering and oncology. He is a contender for the Best Researcher Award, recognized for his outstanding contributions in precision medicine and cancer research, including the development of biomarkers and targeted therapies for various cancers.

Publication 📖

Bladder Cancer Early Progression Key Molecular Events Visualization and Clinical Application
Major Research Program of National Natural Science Foundation of China
Published: January 2024 | Link to publication

Mechanism Study of m5C Methyltransferase NSUN7 Driving Vascular Mimicry in Prostate Cancer
Biomedical Translational Engineering Research Center of Beijing University
Published: January 2023 | Link to publication

Research on Nucleic Acid Delivery of Non-hepatic Targeting Nanozyme Carriers
Open Competition for Nucleic Acid Drugs
Published: November 2022 | Link to publication

Screening of Methyltransferase KMT1A Inhibitors in Bladder Cancer Stem Cells
National Natural Science Foundation of China
Published: December 2021 | Link to publication

Conclusion

Dr. Zhao Yang’s work stands at the forefront of precision oncology, with significant advancements in cancer stem cell research, biomarkers, and novel therapeutic strategies. His research has already contributed valuable insights into cancer diagnosis and treatment, and with further industry collaborations and broader dissemination of his findings, he is poised for even greater accomplishments. Dr. Yang is undoubtedly a strong contender for the Excellence in Research award due to his innovative contributions to cancer research and therapeutic development. 🏆🎯

 

Mahmoud Singer | Immunotherapy of cancer | Best Researcher Award

Published on by Environmental Scientists

Dr Mahmoud Singer | Immunotherapy of cancer | Best Researcher Award

Postdoctoral fellow, School of Medicine, University of California, Irvine, USA, United States🌟

Dr. Mahmoud Singer is a dedicated researcher and postdoctoral scientist specializing in tumor immunology and cancer immunotherapy. 🌿 With expertise in immunology, molecular biology, and radiological sciences, he has contributed significantly to advancing liver and colorectal cancer treatments. His career spans academia and industry, including roles in medical equipment applications and pharmaceutical marketing. 🌎 Based in Los Angeles, USA, Dr. Singer actively pursues innovative therapeutic approaches to improve patient outcomes.

Profile

Google Scholar

Education 🎓

Dr. Singer earned his Doctorate in Biochemistry (Immunology & Cancer Biology) from Ain Shams University, Egypt. 📜 His research introduced novel immunotherapeutic models for liver cancer, integrating cutting-edge techniques in molecular biology and biochemistry. 🌟 With a robust academic foundation, he continues to enhance the field of cancer research.

Experience 🩺

Currently a Postdoctoral Scientist at the University of California, Irvine, Dr. Singer leads groundbreaking research on immunotherapy for hepatocellular carcinoma (HCC) and colorectal cancer. 🧬 His past roles include Onco-Immunologist at City of Hope National Medical Center and Lecturer at Cairo University. Dr. Singer’s work bridges laboratory science and clinical applications. 🥼

Research Interests 🔬

Dr. Singer focuses on immuno-oncology, viral immunology, and vaccines. 💉 His projects include innovative approaches to immune suppression, T-cell therapy, and targeted cancer treatments. His research reflects a passion for translating immunological discoveries into actionable therapies. 🌐

Awards 🏆

Dr. Singer’s efforts in cancer immunotherapy have been recognized with multiple accolades, including contributions to NIH grant applications and patent-pending innovations in BCMA-targeted therapy. 🌟 His dedication to science continues to drive advancements in oncology.

Publications Top Notes 📚

Structural glycoprotein E2 of classical swine fever virus interacts with host protein dynactin subunit 6 (DCTN6) during the virus infectious cycle
Journal of Virology, 94(1), 2019 (Cited by: 14)

Role of TNF-alpha as a survival prognostic marker in chronic lymphocytic leukemia patients
Egypt J Immunol, 18(1), 2011 (Cited by: 13)

Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by …
Frontiers in Immunology, 15, 2024 (Cited by: 11)

Cytokine profiling as a prognostic marker in chronic myeloid leukemia patients
Egypt J Immunol, 18, 2011 (Cited by: 9)

A multi-epitope/CXCL11 prime/pull coronavirus mucosal vaccine boosts the frequency and the function of lung-resident memory CD4+ and CD8+ T cells and …
Journal of Virology, 97(12), 2023 (Cited by: 7)

Mucosal CCL28 Chemokine Improves Protection against Genital Herpes through Mobilization of Antiviral Effector Memory CCR10+ CD44+ CD62L− CD8+ T Cells and Memory CCR10+ B220+ …
The Journal of Immunology, 211(1), 2023 (Cited by: 6)

Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice
Vaccines, 12(3), 2024 (Cited by: 4)

Conclusion

Dr. Mahmoud Singer is highly suitable for the Best Researcher Award, given his significant contributions to cancer immunotherapy, impactful publications, and innovative research in immuno-oncology. 🎖️ With continued focus on leadership and global collaborations, Dr. Singer has the potential to achieve even greater recognition in his field. His commitment to advancing therapeutic strategies and improving patient outcomes makes him a deserving candidate. 🌟